ATAygun Tali̇bOva

Aygun Tali̇bOva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aygun Tali̇bOva has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The impact of intravenous immunoglobulin on kidney functions and thromboembolic events in dermatology patients

    by Ceylan Avcı, Aygün Talibova, Ozlem Ozbagcivan, Cihan Heybeli, Emel Fetil

    Although intravenous immunoglobulin (IVIG) treatment is generally well tolerated, some adverse effects, ranging from mild to severe, can occur. Nephrotoxicity and thromboembolism are the significant adverse effects of IVIG. However, data on the frequency of thromboembolism and the impact of continuous treatment on renal functions in dermatology patients is limited. This retrospective study was conducted in a cohort of patients who received at least one high-dose (2 g/kg) IVIG cycle due to different dermatological indications, including pemphigus vulgaris, bullous pemphigoid, Stevens-Johnson syndrome, pyoderma gangrenosum, hidradenitis suppurativa and toxic epidermal necrolysis at a university hospital. Demographic and clinical information, thromboembolic events, and kidney function tests were systematically extracted from patient records. The study included 48 patients who received a total of 196 IVIG cycles with a mean dose of two cycles (range 1–41). A significant difference in renal function was observed between baseline and post-treatment in patients who received three or more IVIG cycles. In comparison, no significant difference was found in those receiving one or two IVIG cycles. Five patients (10.4%) experienced a decline of ≥ 20% in the estimated glomerular filtration rate (eGFR). In multivariate analysis, cumulative IVIG dose emerged as the sole independent predictor for a ≥ 20% decline in eGFR (OR 1.61, 95% CI 1.05–2.46, p = 0.02). Thromboembolism occurred in five patients (10.4%), with three cases arising during the first cycle. Thromboembolism, especially during the initial IVIG cycles, and decline in kidney functions related to cumulative IVIG dose were the common and significant side effects in this cohort of dermatology patients.


  • Open Access

    Nail Capillaroscopic Findings in Patients with Heart Failure

    by Fatmagül Gülbaşaran, Özlem Özbağci̇vAn, Aygun Tali̇bOva, Mehmet Birhan Yilmaz, Emel Çalikoğlu

    Background and Purpose: The nail (fold) microvasculature can be examined non-invasively with capillaroscopy. The endothelium plays a crucial role in atherosclerosis pathogenesis and, in certain instances, the occurance of heart failure. This study was designed to explore microcirculatory alterations by employing nailfold capillaroscopy in individuals with heart failure. Methods: In this observational, prospective study involving individuals with heart failure and controls, nailfold capillaroscopic findings visualized by dermoscopy were evaluated comparatively between the two groups (SPSS version 28.0). Results: A total of 54 participants, consisting of 24 individuals with heart failure and 30 controls without heart failure were included. Nailfold capillaroscopic characteristics significantly more prevalent in the heart failure group compared to the controls included microhemorrhage (70.8% vs. 36.7%), the irregular distribution (20.4% vs. 11.1%), dilation (45.8% vs. 20%) and tortuosity (58.3% vs. 3.3%) (all p0.05). Conclusion: Nailfold capillaroscopy may serve as a useful and easy method to examine systemic microvascular changes in heart failure patients.